Marfan's syndrome, Marfan syndrome

January 2009
Taber's Cyclopedic Medical Dictionary (2009);2009, Issue 21, p1404
Reference Entry
A definition of the term "Marfan's syndrome" or "Marfan syndrome" is presented, which refers to a hereditary degenerative disorder of connective tissue and bones, muscles, and ligaments caused by a mutation on chromosome 15 which affects about one in 5000-7500 persons .


Related Articles

  • The “Thumb Sign” in Marfan's Syndrome. Falk, Rodney H. // New England Journal of Medicine;8/17/95, Vol. 333 Issue 7, p430 

    The article presents an image of a medical patient displaying the symptoms of Marfan's Syndrome.

  • The Marfanoid Hypermobility Syndrome. Walker, Bryan A.; Beighton, Peter; Murdoch, J. Lamont // Annals of Internal Medicine;Aug69, Vol. 71 Issue 2, p349 

    Focuses on a patient who had the marfanoid habitus but no evidence of involvement of the aorta or dislocation of the lenses. Clinical features of the condition; Suggestion about the marfanoid hypermobility.

  • Marfan Syndrome: Identification And Management. Eaton, Leann; Meiner, Sue E. // MEDSURG Nursing;Apr99, Vol. 8 Issue 2, p113 

    Provides information on the identification and clinical management of the genetic disorder, Marfan's syndrome. Etiology; Pathogenesis; Clinical presentation of the syndrome.

  • MARFAN SYNDROME: The Silent Killer. Williams, Cheryl // USA Today Magazine;Nov89, Vol. 118 Issue 2534, p64 

    Focuses on the nature of the hereditary disorder called Marfan syndrome. Characteristics of the condition; Organs of the body affected by the condition; History of the discovery of the disease; Manifestations and symptoms of Marfan syndrome; Suspected cause of the condition; Tests that can be...

  • Reduced Activity of Serum β-Glucuronidase in Marfan Syndrome. Nakashima, Yasuhide // Angiology;Aug1986, Vol. 37 Issue 8, p576 

    Reduced activity of serum β-glucuronidase (EC was found in three patients with Marfan syndrome, two of whom were siblings. The serum β-glu-curonidase levels in the patients ranged from 294 to 439 μg (360.7± 73.2, mean±SD) of the released P-nitrophenol/100 ml of...

  • Aortic Root Repair for Thoracic Aorta False Aneurysm Following Bentall Procedure Kumar, Sanjay; Jones, Steve; Sivananthan, U.M.; McGoldrick, J.P. // Heart, Lung & Circulation;Aug2008, Vol. 17 Issue 4, p334 

    The Bentall procedure for aortic root replacement in Marfan''s syndrome is safe and durable. We describe successful repair of periprosthetic valvular leak, 12 years following Bentall repair with composite graft. The aim of this report is to analyse and evaluate technical factors leading to this...

  • A Small Molecule for a Large Disease. Pyeritz, Reed E. // New England Journal of Medicine;6/26/2008, Vol. 358 Issue 26, p2829 

    The author reflects on treatment options which have been developed for patients with Marfan's syndrome and on research which has examined the effectiveness of the treatment options. He suggests that if patients are not eligible to participate in a clinical trial then the best treatment choice...

  • Don't Miss the Signs of Marfan Syndrome.  // Review of Optometry;7/15/2012, Vol. 149 Issue 7, p12 

    The article presents information on a survey conducted by the National Marfan Foundation (NMF) according to which optometrists must become increasingly familiar with the early signs and symptoms of Marfan syndrome. It has been warned that Marfan syndrome may lead to aortic tear or rupture if not...

  • Management of Marfan syndrome. Dean, John C.S. // Heart;Jul2002, Vol. 88 Issue 1, p97 

    Focuses on the management of Marfan syndrome, an autosomal dominant connective tissue disorder. Clinical characteristics; Life expectancy; Diagnosis; Cardiovascular complications in Marfan syndrome; Pathophysiology and medical management; Surgical management.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics